D. E. Shaw & Co., Inc. - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 111 filers reported holding FIBROGEN INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$625,121
+584.4%
724,442
+2041.4%
0.00%
Q2 2023$91,341
-51.5%
33,830
+235.0%
0.00%
Q1 2023$188,466
+14.2%
10,100
-20.2%
0.00%
Q3 2022$165,000
-90.9%
12,660
-81.5%
0.00%
-100.0%
Q2 2021$1,819,000
+70.3%
68,295
+163.0%
0.00%
+100.0%
Q3 2020$1,068,000
-66.3%
25,965
-66.8%
0.00%
-66.7%
Q2 2020$3,170,000
+352.2%
78,230
+378.3%
0.00%
+200.0%
Q4 2019$701,000
-12.9%
16,355
-24.9%
0.00%0.0%
Q3 2019$805,000
+16.5%
21,775
+42.4%
0.00%0.0%
Q2 2019$691,000
-90.9%
15,291
-90.7%
0.00%
-90.0%
Q4 2018$7,575,000
+1883.0%
163,677
+2500.9%
0.01%
Q3 2018$382,000
-70.2%
6,293
-73.6%
0.00%
-100.0%
Q3 2017$1,284,000
+50.4%
23,861
-9.8%
0.00%
+100.0%
Q2 2017$854,000
+1.1%
26,442
-22.8%
0.00%0.0%
Q1 2017$845,000
-52.3%
34,269
-58.6%
0.00%
-66.7%
Q4 2016$1,772,000
+20.6%
82,826
+16.8%
0.00%0.0%
Q3 2016$1,469,000
+2.6%
70,928
-18.8%
0.00%0.0%
Q2 2016$1,432,000
-39.6%
87,311
-21.5%
0.00%
-25.0%
Q1 2016$2,369,000
-68.3%
111,267
-54.7%
0.00%
-63.6%
Q4 2015$7,478,000
+77.2%
245,408
+27.5%
0.01%
+83.3%
Q3 2015$4,220,000
+10.0%
192,534
+18.0%
0.01%0.0%
Q2 2015$3,836,000
+752.4%
163,224
+891.5%
0.01%
+500.0%
Q4 2014$450,00016,4630.00%
Other shareholders
FIBROGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 195,707$168,8760.11%
ARMISTICE CAPITAL, LLC 7,892,000$6,810,0070.10%
Nan Fung Group Holdings Ltd 62,106$53,5910.04%
XTX Topco Ltd 174,496$150,5730.03%
BHK Investment Advisors, LLC 57,625$49,7250.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,557,128$2,206,5460.01%
FOX RUN MANAGEMENT, L.L.C. 42,720$36,8630.01%
PRIMECAP MANAGEMENT CO/CA/ 14,724,968$12,706,1750.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 38,634$4,0020.01%
Point72 Middle East FZE 342,385$295,4440.01%
View complete list of FIBROGEN INC shareholders